Tech Company Financing Transactions
Thyritope Biosciences Funding Round
On 9/23/2014, Thyritope Biosciences raised $10 million in Series A investment from Avalon Ventures and GlaxoSmithKline.
Transaction Overview
Company Name
Announced On
9/23/2014
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Avalon Ventures (Jay Lichter)
GlaxoSmithKline (Lon Cardon)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA 92037
USA
San Diego, CA 92037
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Thyritope Biosciences is developing therapeutics that target thyroid stimulating auto-antibodies, which are the causative drivers of Graves' hyperthyroidism and Graves' orbitopathy. Graves' disease is an autoimmune disorder caused by antibodies that over-stimulate the thyroid, causing excessive thyroid hormone production.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Patrick Daugherty
Browse more venture capital transactions:
Prev: 9/23/2014: CurbStand venture capital transaction
Next: 9/23/2014: PicnicHealth venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs